Luca Prosperini

Area of research

Pathology and Forensic Medicine · Oncology

Research interest

Research focused on Multiple sclerosis and Natalizumab, with related work in Teriflunomide, Discontinuation, Progressive multifocal leukoencephalopathy. Notable publications include 'Post-natalizumab disease reactivation in multiple sclerosis: systematic review and meta-analysis', 'Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study', and 'No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study'.

The brain-boosting power of exergames in neurological disabilities

Technology and Disability 2025cited by 2position: firstdoi

Epilepsy in MS and its association with cognitive and psychological burden

Multiple Sclerosis Journal - Experimental Translational and Clinical 2025cited by 2position: middledoi

Brain bright spotty lesions and leukodystrophy-like patterns in NMOSD relapse

Multiple Sclerosis and Related Disorders 2025cited by 0position: middledoi

Real-world experience with cladribine tablets in people with multiple sclerosis: effectiveness data from a multicenter Italian study

Therapeutic Advances in Neurological Disorders 2025cited by 0position: middledoi

De-escalating and discontinuing disease-modifying therapies in multiple sclerosis

Brain 2024cited by 22position: middledoi

Incidence and determinants of seizures in multiple sclerosis: a meta-analysis of randomised clinical trials

Journal of Neurology Neurosurgery & Psychiatry 2024cited by 6position: lastdoi

Concurrent management of multiple sclerosis and natalizumab-induced hepatitis with ofatumumab: a case report

Neurological Sciences 2024cited by 5position: middledoi

Cortical plasticity in AQP4-positive NMOSD: a transcranial magnetic stimulation study

Cerebral Cortex 2024cited by 3position: middledoi

Correction to: Concurrent management of multiple sclerosis and natalizumab‑induced hepatitis with ofatumumab: a case report

Neurological Sciences 2024cited by 0position: middledoi

Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study

Journal of Neurology Neurosurgery & Psychiatry 2023cited by 17position: middledoi

Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study

Journal of Neurology 2021cited by 22position: lastdoi

Post-natalizumab disease reactivation in multiple sclerosis: systematic review and meta-analysis

Therapeutic Advances in Neurological Disorders 2019cited by 100position: firstdoi

Exit strategies for “needle fatigue” in multiple sclerosis: a propensity score-matched comparison study

Journal of Neurology 2019cited by 10position: firstdoi

No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study

Journal of Neurology 2018cited by 54position: firstdoi

Early diagnosis of progressive multifocal leucoencephalopathy: longitudinal lesion evolution

Journal of Neurology Neurosurgery & Psychiatry 2018cited by 24position: middledoi

Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study

Journal of Neurology 2016cited by 57position: middledoi

Recent publications

Grants

Frequent collaborators